Aims/hypothesis The aim of this study was to investigate the function of Prep1 (also known as Pknox1) in hepatic lipogenesis. Methods The hepatic lipogenesis pathway was evaluated by real-time RT-PCR and Western blot. Biochemical variables were assessed using a clinical chemistry analyser. Results Serum triacylglycerols and liver expression of fatty acid synthase (FAS) were significantly decreased in Prep1 hypomorphic heterozygous (Prep1 i/+ ) mice compared with their non-hypomorphic littermates. Upstream FAS expression, phosphorylation of protein kinase C (PKC)ζ, liver kinase B1 (LKB1), AMP-activated protein kinase (AMPK) and acetylCoA carboxylase (ACC) increased in Prep1 i/+ mice, while protein and mRNA levels of the lipid phosphatase inhibitor of PKCζ, SH2-containing inositol 5′-phosphatase 2 (SHIP2), was more than 60% reduced. Consistent with these findings, HepG2 cells transfected with Prep1 cDNA exhibited increased triacylglycerol accumulation and FAS expression, with strongly reduced PKCζ, LKB1, AMPK and ACC phosphorylation. Further experiments revealed the presence of both Prep1 and its major partner Pbx1 at the Ship2 (also known as Inppl1 ) promoter. PBX-regulating protein 1 (PREP1) and pre-B cell leukaemia transcription factor 1 (PBX1) enhanced Ship2 transcription. The PREP1 HR mutant, which is unable to bind PBX1, exhibited no effect on Ship2 function, indicating transcriptional activation of Ship2 by the PREP1/PBX1 complex. Treatment with a methionine-and choline-deficient diet (MCDD) induced steatosis in both Prep1 i/+ and non-hypomorphic control mice. However, alanine aminotransferase increase, intracellular triacylglycerol content and histological evidence of liver steatosis, inflammation and necrosis were significantly less evident in Prep1 i/+ mice, indicating that Prep1 silencing protects mice from MCDD-induced steatohepatitis. Conclusions/interpretation Our results indicate that Prep1 silencing reduces lipotoxicity by increasing PKCζ/LKB1/ AMPK/ACC signalling, while levels of PREP1 expression may determine the risk of steatohepatitis and its progression.
Introduction
The liver has a very important role in lipid homeostasis and metabolism [1] . In the liver, an excess of carbohydrates results in insulin-dependent de novo fatty acid synthesis. This effect is largely accomplished through the downregulation of AMPactivated protein kinase (AMPK) [2] . Indeed, AMPK phosphorylates and inactivates acetyl-CoA carboxylase (ACC), inhibiting fatty acid biosynthesis [3, 4] . AMPK activation requires phosphorylation at Thr172 by one or more upstream kinases, including liver kinase B1 (LKB1) [5, 6] .
In addition to the de novo synthesis of fatty acids, however, other events can cause the intrahepatic accumulation of lipids, including increased lipid uptake, impaired lipoprotein secretion or synthesis and reduced fatty acid oxidation [7] . Insulin resistance can impact on several of these processes, leading to excess liver fat deposition and non-alcoholic fatty liver disease (NAFLD). NAFLD, in turn, facilitates oxidative hepatocellular damage, inflammation and activation of fibrogenesis. The resulting non-alcoholic steatohepatitis (NASH) can progress towards cirrhosis and hepatocellular carcinoma. NAFLD represents the most common liver disease and the leading cause of altered liver enzymes in Western countries [8] . Its development parallels that of insulin resistance and it is associated with type 2 diabetes mellitus [9] .
Epidemiological, familial and twin studies provide strong evidence for NAFLD heritability [10, 11] . Genetic modifiers of disease severity and progression have been identified through genome-wide association studies [8, 12, 13] . Furthermore, a few large multicentre studies have demonstrated the role of gene variants implicated in insulin signalling, oxidative stress and fibrogenesis in the progression of NAFLD towards NASH and fibrosis [12, 14] . These studies also confirmed the significance of intrahepatocyte fat accumulation and systemic insulin resistance for the progression of liver damage. However, the genetic bases of NAFLD and NASH risk and the relationship with insulin resistance are far from clear.
Pre-B cell leukaemia transcription factor-regulating protein 1 (PREP1) is a homeodomain transcription factor belonging to the TALE family of proteins. This family of proteins also includes the PBX (PBX1-4) and MEIS (MEIS1-3) transcription factors, and plays an important role in haematopoiesis, organogenesis and development. Both PREP and MEIS contain homologous conserved PBX-interacting motifs (HR1 and HR2 domains) and form transcriptionally active complexes with PBX [15] [16] [17] . However, while PREP1's main interactor is PBX1, MEIS1 is most involved in interactions with HOX proteins; likewise, while PREP1 acts mainly at promoter sites, MEIS1 acts mainly at promoter-distant sites [18] . As complete Prep1 (also known as Pknox1) knockout is lethal, previous work has shown that Prep1 hypomorphic heterozygous (Prep1 i/+ ) mice feature a complex phenotype characterised by increased insulin sensitivity and protection from streptozotocin-induced diabetes [19] . These animals also feature decreased hepatic triacylglycerol (TG) content, raising the hypothesis that Prep1 may impact not only on glucose, but also on lipid metabolism in the hepatocyte [20] .
In this work, we have addressed this issue and investigated the function of Prep1 on fatty acid metabolism and TG accumulation in liver. We show that the PREP1/PBX1 complex upregulates transcription of the lipid phosphatase Ship2 (also known as Inppl1 ), thereby controlling the protein kinase C (PKC)ζ/LKB1/AMPK/ACC signalling cascade, fatty acid synthase (FAS) expression and TG accumulation in liver cells. On the basis of these results, Prep1 might be considered a new gene involved both in the pathogenesis of insulin resistance and steatohepatitis.
Methods
Materials Media, sera, antibiotics for cell culture and the Lipofectamine reagent were all from Invitrogen (Grand Island, NY, USA). The pRC/CMV-Prep1 , pSG5-Pbx1 and PSG5-Prep1 HR1 vectors have been previously described [20, 21] . PREP1, actin, PBX1, SH2-containing inositol 5′-phosphatase 2 (SHIP2), pACC, ACC, AMPK, LKB1, calcium/ calmodulin-dependent protein kinase kinase β (CAMKKβ), pPKCζ, PKCζ, phosphorylated protein kinase A (pPKA) and PKA antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). pLKB1, pCAMKKβ and pAMPK antibodies were from Cell Signaling Technology (Beverly, MA, USA). Protein electrophoresis and real-time PCR reagents were from Bio-Rad (Richmond, VA, USA). Western blotting and ECL reagents were from Amersham Biosciences (Arlington Heights, IL, USA). Oil Red O (ORO) stain and all other chemicals were from Sigma (St Louis, MO, USA).
Studies in mice Prep1-targeted mice were generated by gene trapping by Lexicon Genetics (The Woodlands, TX, USA). The general phenotype of these mice has been previously described [21] [22] [23] . In the experiments reported in this paper, Prep1 i/+ mice were backcrossed with wild-type (WT) C57BL/6J mice for generations. All animal handling conformed to regulations of the Ethics Committee on Animal Use of H. S. Raffaele (IACUC permission number 207). The genotyping strategy has been previously described [19] . Hepatic tissue samples were collected rapidly from 8-to 10-week-old male C57BL/6-SV129 mice. Tissues were snapfrozen in liquid nitrogen and stored at −80°C for subsequent western blotting and real-time RT-PCR analysis, as previously described [19] .
The blood for serum biochemistry evaluation was collected with an intracardiac method, allowed to clot at room temperature and centrifuged for 10 min; the serum was then separated for shipment. Quantitative analysis of serum TGs was performed with an ABX Pentra400 clinical chemistry analyser using the reagent ABX Pentra Triacylglycerols CP (ABXHoriba, Montpellier, France) according to the manufacturer's instructions. Serum VLDL-cholesterol and -triacylglycerol levels were measured with ELISA kits (USCN Life Science, Houston, TX, USA).
Methionine-and choline-deficient diet Nine-week-old male C57BL/6-SV129 mice (WT and Prep1 i/+ ) were divided into four groups. Two groups of mice (n = 9 WT and n = 9 Prep1 i/+ ) were fed a standard rodent chow diet. The other two groups of mice (n =9 WT and n =9 Prep1 i/+ ) were fed a methionine-and choline-deficient diet (MCDD). All of the animals were maintained in a temperature-and lightcontrolled facility, and permitted ad libitum consumption of food and water throughout the 4 weeks of the experimental period. Body weights were measured every week. The animals were killed after overnight fasting for tissue sampling. Blood was collected by cardiac puncture, and the livers were isolated, immediately freeze-clamped in liquid nitrogen and stored at −80°C until analysis. Serum levels of alanine aminotransferase (ALT) and TG were assayed using an ABX Pentra400 clinical chemistry analyser. TG content was extracted from frozen liver tissues and determined as previously described [20] .
For the histological examination, livers from killed mice were immediately incised and weighed. Small pieces from each lobe were fixed in 10% formalin and stained with haematoxylin and eosin and ORO for histological analysis. The histological features were grouped into five broad categories: steatosis, inflammation, hepatocellular injury, fibrosis and miscellaneous features. The system of evaluation was adapted from the original proposed by Kleiner et al [24] for the histological evaluation of NASH and took into account the following histological variables: steatosis grade (quantified by low-to medium-power evaluation of parenchymal involvement by steatosis): score 0, <5%; score 1, 5-33%; score 2, >33-66%, score 3, >66%; location (predominant distribution pattern): zone 3, score 0; zone 1, score 1; azonal, score 2; inflammation: lobular inflammation (overall assessment of all inflammatory foci): score 0, no foci; score 1, <2 foci per ×200 field; score 2, 2-4 foci per ×200 field; score 3, >4 foci per ×200 field; necrosis: score 0, present; score 1, absent.
Cell culture procedures and transfection Human hepatocellular carcinoma (HepG2) cells and NMuLi mouse liver cells were cultured at 37°C in DMEM supplemented with 10% FBS, 2% L -glutamine, 10,000 units/ml penicillin and 10,000 μg/ml streptomycin. Transient transfection of Prep1, Prep1 HR1 and Pbx1 plasmids or Ship2 (5′-GCTCTCTAGTTCCTGCTCCC-3′) phosphorothioate antisense oligonucleotides or Ship2 (5′-TCGCCACGTCGCTCATTGTT-3′) control scrambled oligonucleotides were performed by the Lipofectamine method according to the manufacturer's instruction (Invitrogen). PREP1 stable clones were selected as previously described [20] .
ORO staining To measure cellular neutral lipid droplet accumulation, HepG2 cells were stained by the ORO method as previously described [25] .
Western blot analysis Tissue samples were homogenised in a Polytron Homogenizer (Brinkmann Instruments, NY, USA) in 20 ml T-PER reagent (g tissue) -1 according to the manufacturer's instructions (Pierce, IL, USA). Total cell lysates were obtained and separated by SDS-PAGE as previously described [26] .
Real-time RT-PCR analysis Total cellular RNA was isolated from liver tissue and HepG2 cells using the RNeasy Kit (Qiagen Sciences, Germantown, MD, USA), according to the manufacturer's instructions. A total of 1 μg of tissue or cell RNA was reversetranscribed using SuperScript II Reverse Transcriptase (Invitrogen). PCR reactions were analysed using SYBR Green mix (Bio-Rad, Hercules, CA, USA). Reactions were performed using the Platinum SYBR Green qPCR SuperMix-UDG using an iCycler IQ Multi-Color Real Time PCR Detection System (Bio-Rad). All reactions were performed in triplicate and β-actin was used as an internal standard. The primer sequences used are described in electronic supplementary material (ESM) Table 1 .
Chromatin immunoprecipitation and luciferase assays
Chromatin immunoprecipitation (ChIP) and re-ChIP assays were performed using NMuLi cells as previously described [27] . For luciferase assays, the mouse Ship2 fragment −1,385 bp to −1,115 bp was amplified by PCR from genomic mouse DNA isolated from the murine liver cell line (NMuLi cells). The following primers were used: forward: 5′-KpnI-CAAAGGGGAAGCTGGAAACGGGA-3′ and reverse: 5′-XhoI-TTAGCCGAAGGCTAGAGGGTGCT-3′, where KpnI and XhoI indicate the restriction sites added to the sequence. The amplified fragments were cloned in the pGL3 promoter vector (Promega, Madison, WI, USA) by KpnI and XhoI. NMuLi cells were cotransfected with 2 μg of Ship2 promoter vector together with different amounts of Prep1 and Pbx1 expression vectors. Total DNA content (up to 4 μg/plate) was normalised to the empty vector devoid of Prep1 and Pbx1 coding sequence. Forty-eight hours after transfection the cells were harvested and lysed as described previously [27] . Luciferase activity was measured by a commercial luciferase assay kit (Promega). Values were normalised for beta-galactosidase.
Statistical procedures Data were analysed with StatView software (Abacus Concepts, Piscataway, NJ, USA) by two-factor ANOVA. p values of <0.05 were considered statistically significant [28] .
Results
Prep1 impact on lipogenesis-controlling signalling events in mouse liver Serum TG content, but not hepatic ApoB100 (also known as Apob) expression or serum VLDL secretion, was reduced by 33% in Prep1 i/+ mice compared with their nonhypomorphic littermates (WT) (Fig. 1a-c ). Fas expression decreased by 65% in Prep1 i/+ compared with WT mice, while Acc and Srebp-1c (encoding sterol regulatory element binding protein-1c) were not significantly affected in Prep1 i/+ mice (Fig. 1d) . To investigate this issue in greater detail, we first focused our attention on one of the major lipogenesis regulatory enzymes, AMPK, and on its downstream target, ACC. Active AMPK, phosphorylated at Thr172, was significantly upregulated in Prep1 i/+ mice, with no change in AMPK protein levels. Indeed, the pAMPK to AMPK ratio was threefold higher in Prep1 i/+ compared with WT mice. The expression and phosphorylation of ACC at Ser79 closely matched those of AMPK (Fig. 2a) . We next examined the upstream signalling mechanisms converging on AMPK and assayed phosphorylation of both LKB1 and CAMKKβ. As shown in Fig. 2b enhanced phosphorylation, as phosphorylation of PKA was very comparable in Prep1 i/+ and WT mice (Fig. 2b) . To further explore the impact of PREP1 on hepatic lipogenesis, we transiently transfected Prep1 cDNA in HepG2 cells (Fig. 3a) . We then analysed the lipid accumulation in these cells by ORO staining. As shown in Fig. 3b , ORO staining was twofold higher in Prep1 -overexpressing cells than in controls transfected with an empty vector. Fas, but not Acc, mRNA levels also increased by 50% in the Prep1-transfected cells (Fig. 3c) , while phosphorylation of PKCζ, LKB1, AMPK and ACC was significantly reduced (Fig. 3d) .
Prep1 regulates hepatic lipogenesis via Ship2 PREP1 regulation of hepatic gluconeogenesis occurs through a PREP1/ PBX1 complex [20] . We therefore hypothesised that PBX1 co-regulates the PREP1 action on lipogenesis. To examine this possibility, we transfected HepG2 cells with either Pbx1 or Prep1 HR1 cDNA. The latter is unable to bind and form a complex with PBX1 [21] . Similarly to PREP1, PBX1 was found to downregulate the PKCζ/LKB1/AMPK/ACC phosphorylation cascade and induce Fas expression and intracellular lipid droplet accumulation in the liver cells. In contrast, Prep1 HR1 transfection elicited no effect on these mechanisms, indicating that PBX1 binding is necessary for PREP1 control of lipogenesis (ESM Fig. 1 ).
Published evidence indicates that the lipid phosphatase SHIP2 reduces cellular levels of phosphatidylinositol-3-kinasegenerated phosphatidylinositol-3-phosphate and PKCζ activation [31] [32] [33] . Interestingly, SHIP2 protein and mRNA levels in the livers of Prep1 i/+ mice were reduced by more than 60% compared with WT (Fig. 4a, b) . Transfection of either Prep1 or Pbx1 cDNAs in HepG2 cells induced a close to twofold increase in SHIP2 protein and mRNA expression, while transfection of the Prep1 HR1 mutant caused no change (Fig. 4c, d ). We therefore used Ship2-specific antisense oligonucleotides to test the hypothesis that SHIP2 represents a downstream mediator of the PREP1/PBX1 action on hepatic lipogenesis. Indeed, transfection of Ship2 -specific antisense oligonucleotides in HepG2 PREP1c cells (which overexpress Prep1 by fivefold) [20] caused a 75% reduction in SHIP2 levels and, in parallel, generated a phenotype similar to that observed in Prep1 i/+ mice, with a more than fourfold increase in AMPK and ACC phosphorylation and downregulated Fas, but not Acc, expression (Fig. 5 ). PKCζ and LKB1 phosphorylation was also significantly induced in Ship2-specific antisense oligonucleotide transfected cells (data not shown).
Prep1 regulation of Ship2 gene transcription Bioinformatic analysis revealed the presence of a potential PREP1/PBX1 binding site at position −1,284 to −1,268 upstream of the transcription initiation site of the Ship2 gene (Fig. 6a) . To validate this putative region, we used specific antibodies against either PREP1 or PBX1 and performed ChIP and reChIP studies in NMuLi mouse liver cells. These experiments revealed the simultaneous presence of both Prep1 and Pbx1 at the putative binding site (Fig. 6b) . We than cloned the PREP1/ PBX1 binding fragment into a pGL3 promoter construct upstream of the luciferase gene. This construct was then cotransfected into NMuLi cells together with Prep1, Pbx1, both the transcription factors and Prep1 HR1 cDNAs, followed a b
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Ctrl Prep1 (Table 1) , which was independent of food intake (data not shown). Liver weight also comparably decreased in both of the mice groups upon diet administration. Both serum ALT and TG levels were lower in the Prep1 i/+ mice at baseline. Interestingly, the increase in ALT levels and decrease in TG levels following the regimen was significantly less pronounced in Prep1 i/+ compared with control mice. In addition, MCDD-induced accumulation of TGs was 25% reduced in Prep1 i/+ mouse liver (Fig. 7a) . Indeed, livers from MCDD-fed WT mice revealed very significant morphological evidence of steatosis (score 2-3) accompanied by severe lobular inflammation (score 2-3) and foci of necrosis (Fig. 7b) as indicated by the arrows. In comparison, Prep1 i/+ mice showed only grade 1 hepatic steatosis, grade 0-1 inflammation and absence of necrosis. In addition, little ORO staining accumulation occurred in these mice in comparison with their non-hypomorphic littermates. When fed a regular chow diet, these animals showed no histological differences in livers, suggesting that PREP1 expression levels determine the hepatocyte sensitivity to a steatogenic diet.
Discussion
NAFLD spans from steatosis to NASH, with lobular inflammatory and necrotic lesions and fibrosis [34] . Metabolic abnormalities, including dysregulated insulin signalling and action, and nutritional and genetic factors are well-established contributors to the onset and progression of these liver disorders [7] . Indeed, patients with insulin resistance syndrome have a four-to eleven-fold increased risk of developing NAFLD [9] . In addition, small-interfering-RNA-mediated suppression of IRS1 and IRS2 results in hepatic insulin resistance, glucose intolerance and hepatic steatosis in rodents [35, 36] . However, the identity of the genes affecting the risk of NAFLD and of NASH as well as the molecular mechanisms involved in their function have been only partially uncovered. Previous work in our laboratory revealed that PREP1 attenuates insulin glucoregulatory function in liver by transcriptional activation of the Shp1 (also known as Ptpn6) gene, a known silencer of insulin signalling [20] . In addition, we showed that Prep1 i/+ mice feature reduced hepatic TG content. In the present work, we demonstrate that these mice also exhibit depressed serum TG levels. This effect is not due to changes in VLDL secretion or in hepatic ApoB100 expression, which are required for TG transport in plasma [37] . However, we found that the reduced serum TG level featured by the Prep1 i/+ mice was accompanied by reduced Fas expression, prompting us to explore the hypothesis that PREP1 also controls hepatic lipid synthesis. Indeed, we have shown that, in livers from Prep1 i/+ mice, the major inhibitor of de novo lipogenesis, AMPK, was strongly induced, accompanied by an increase in ACC phosphorylation. AMPK regulates hepatic lipid metabolism by exerting short-and longterm effects. Short-term regulation includes AMPK phosphorylation and inactivation of ACC, thereby inhibiting fatty acid biosynthesis. Long-term effects include AMPK regulation of lipogenesis by inhibition of SREBP-1c and promotion of lipogenic gene expression, such as Acc and Fas [3] . Because Srebp-1c and Acc expression were not reduced in Prep1 i/+ mice, the short-term effects of AMPK might have prevailed in these Prep1 i/+ mice. Indeed, PKCζ/LKB1 signalling was also induced in Prep1-deficient mouse liver. Work by Luna and co-workers has demonstrated that metformin-induced activation of AMPK is accompanied by induction of PKCζ [38] . Importantly, genetic ablation as well as pharmacologic inhibition of PKCζ prevent stimulation of both LKB1 and AMPK [29] , indicating that PREP1 lipogenic signalling upstream of AMPK involves PKCζ upregulation. Consistent with this mechanism, we show that Prep1 overexpression in liver cells downregulates PKCζ function and AMPK activity and enhances lipid accumulation. Previous work in our laboratory demonstrated that Prep1 silencing enhances liver insulin sensitivity and insulin-dependent glycogen synthesis [20] . In contrast, lipogenesis was downregulated in the Prep1 i/+ mice. Downregulation of lipogenesis might be independent of and prevailing on the enhanced insulin sensitivity caused by Prep1 silencing. In addition, the increased liver sensitivity to insulin might be confined to glycogen synthesis and not present in other pathways.
In vivo, genetic ablation of the inositol phosphate phosphatase SHIP2 determines a phenotype reminiscent of that of Empty vector 
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i/+ mice. First, both Ship2-null mice and Prep1 i/+ mice feature enhanced peripheral sensitivity to insulin [39] . Second, serum TG levels are significantly reduced in both of these genetic models [39] , raising the possibility that, at least in part, the Prep1 i/+ mouse phenotype is determined by reduced Ship2 expression and/or function. This proved to be correct, as Ship2 mRNA as well as protein levels were found to be strongly reduced in the livers of Prep1 i/+ mice, while the opposite changes occurred in liver cells transfected with Prep1 cDNA. Of importance, antisense silencing of Ship2 in hepatocytes prevents signalling activation through the PKCζ/LKB1/AMPK cascade and Fas induction caused by PREP1 overexpression. These findings indicate that the Ship2 gene represents a transcriptional target of PREP1, upstream of the AMPK control of hepatic lipogenesis. The SHP1 and SHP2 tyrosine phosphatases are also upregulated by PREP1 [20] . Both of these phosphatases may silence PKCζ by attenuating insulin signalling in cells expressing increased levels of Prep1. In addition, recent work by Nagata and co-workers revealed that liver-specific ablation of SHP2 protects mice from developing liver steatosis [40] . However, antisense silencing of SHP1, SHP2 or both of these phosphatases in liver cells has negligible effects on the increased TG synthesis caused by PREP1 overexpression (data not shown), indicating a marginal, if any, role in PREP1 control of liver lipogenesis. The mechanistic details involved in PREP1 control of SHIP2 function and the hypothesis that they may include direct transcriptional regulation are addressed in the present paper. We first identified a putative PREP1 binding site in the Ship2 regulatory region upstream of the transcription initiation site of the gene. Subsequent ChIP experiments demonstrated PREP1 binding to this putative site. In addition, we have shown that this binding enhances Ship2 reporter activity in luciferase assays. These results are also supported by the analysis of ChIPsequencing experiments performed on human A549 cells overexpressing PREP1, which identified a weak PREP1 binding site about 1.3 kb upstream of the Ship2 transcription start site. Moreover, in NIH 3T3-L1 pre-adipocytes, the downregulation of Prep1 induces the loss of the H3K4Me1 chromatin mark, which is specific for enhancers; this effect is not generalised to other genes (data not shown).
Further ChIP/re-ChIP experiments revealed the simultaneous presence of the major PREP1 co-regulatory factor PBX1 [15] at the Ship2 promoter. We showed that PBX1 is required for PREP1 regulation of lipogenesis since: (1) PBX1 mimics PREP1 signalling through the SHIP2/PKCζ/LKB1/ AMPK/ACC cascade; and (2) expression of the PREP1 HR1 mutant, which is unable to bind PBX1, prevents PBX1 recruitment at the Ship2 promoter and, simultaneously, prevents the induction of lipogenic signalling. Previous studies in liver have demonstrated that PREP1 controls insulin glucoregulatory function by transcriptional targeting of the Shp1 tyrosine phosphatase [20] . As in the case of lipogenesis, overexpression of PBX1 mimics PREP1 action on glucose homeostasis. Thus, in the liver, transcriptional targeting of both lipid and tyrosine phosphatases occurs in partnership with PBX1.
An MCDD results in liver injury similar to human NASH [41] . In addition to increased fatty acid uptake and decreased VLDL secretion, enhanced lipogenesis contributes to the hepatic accumulation of TGs in livers of MCDD-treated mice [42] . Similar mechanisms may predispose to hepatocyte i/+ mice fed a control diet and MCDD. Liver sections were stained with haematoxylin and eosin (H&E) or ORO and examined by light microscopy with a magnification of ×40; arrows show foci of steatosis, inflammation and necrosis damage in human NASH [43] . However, the molecular and genetic mechanisms responsible for NASH have been only partially uncovered. In the present report, we show that silencing of the Prep1 gene protects mice from the TG accumulation and hepatocyte damage caused by MCDD administration, indicating that PREP1 may represent a molecular link between insulin resistance and the development of hepatic steatosis. Whether PREP1 itself or nearby loci affect lipid metabolism or are implicated in NAFLD in humans remains to be clarified. Current evidence indicates that PREP1 expression is increased in patients with alcoholic steatohepatitis, supporting the hypothesis that PREP1 may also have a role in humans [44] .
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